Shares of PacBio Tripled in 2013 Amid Strong Year for Biotech Stocks; Affymetrix, Illumina Among Big Gainers | GenomeWeb

NEW YORK (GenomeWeb News) – While 2013 was a very good year in general for the stock market, biotech stocks, including those of omics tools and molecular diagnostics firms, provided a particularly strong return for investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.